Outcomes4Me Secures $21M in Funding Learn more >>

Learn | Resources to take control of your cancer

Explore articles on personalized treatment options, clinical trials,
and symptom management to empower every step of your journey.

Find the best app for breast cancer patients to track symptoms, manage treatment, and get support. Discover top-rated tools for your care and peace of mind.
Get clear answers about the metastatic prostate cancer survival rate, what affects your outlook, and how treatment and lifestyle choices can make a difference.
Find the best cancer treatment and symptom tracker app to organize your care, track symptoms, and support better communication with your healthcare team.
Find the best app for managing cancer symptoms with these top picks. Track side effects, get reminders, and connect with support—all from your phone.
Find the best app for breast cancer symptom tracking with these top picks. Stay organized, track symptoms, and support your health with easy-to-use tools.
Get clear answers on NSCLC first line treatment, including options, side effects, and how biomarker testing shapes your personalized lung cancer care plan.
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...
You may be potentially eligible for the DYNASTY Breast-02 Clinical trial. To learn more information,...
"Participating in a clinical trial was not only a valuable part of my treatment plan...
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...